Skip to main content
Journal of Preventive Medicine and Hygiene logoLink to Journal of Preventive Medicine and Hygiene
. 2025 Jan 31;65(4):E499–E514. doi: 10.15167/2421-4248/jpmh2024.65.4.3071

Global Disparities in Colorectal Cancer: Unveiling the Present Landscape of Incidence and Mortality Rates, Analyzing Geographical Variances, and Assessing the Human Development Index

DARMADI DARMADI 1, ABDOLLAH MOHAMMADIAN-HAFSHEJANI 2,, SOLEIMAN KHEIRI 3
PMCID: PMC11870140  PMID: 40026425

Summary

Background

Colorectal cancer poses a major global health threat, with increasing incidence and mortality rates worldwide. This study examined the incidence and mortality rates of colorectal cancer globally in 2020 and explored the relationship with the Human Development Index (HDI).

Material and methods

This research utilizes data from the International Agency for Research on Cancer’s (IARC) GLOBOCAN 2020 project, an esteemed source of up-to-date international cancer statistics. Age-standardized incidence rates (ASIR) and age-standardized mortality rates (ASMR) per 100,000 individuals were calculated. The association between ASIR, ASMR, and the HDI was analyzed using Pearson correlation, considering a statistical significance threshold of p < 0.05.

Results

In 2020, a total of 1,931,590 new colorectal cancer cases were recorded globally, with a male predominance of 55.18%. The global colorectal cancer ASIR was 19.5 per 100,000 (23.4 in males, 16.2 in females). Furthermore, there were 935,173 colorectal cancer-related mortality, with males accounting for 55.13%. The overall colorectal cancer ASMR was 9 (11 in males, 7.2 in females). A strong positive correlation emerged between ASIR and ASMR (0.895, p ≤ 0.001), HDI (0.794, p ≤ 0.001), life expectancy (0.724, p ≤ 0.001), education (0.743, p ≤ 0.001), and income (0.706, p ≤ 0.001). Similarly, positive correlations were also found between ASMR and HDI (0.638, p ≤ 0.001), life expectancy (0.569, p ≤ 0.001), education (0.631, p ≤ 0.001), and income (0.512, p ≤ 0.001).

Conclusions

This global analysis highlights rising colorectal cancer incidence and mortality as a major public health threat worldwide. The findings reveal a positive association between a country’s development level, as measured by HDI, and colorectal cancer incidence and mortality.

Keywords: Incidence, Mortality, Colorectal cancer, Geographical disparities, Human Development Index

Introduction

Colorectal cancer poses a major global health concern, with rising incidence and mortality rates worldwide [1, 2]. In 2018, there were 1,849,518 new cases of colorectal cancer, accounting for 10% of all newly diagnosed cancers globally [3]. Additionally, there were 880,792 deaths attributed to colorectal cancer, representing 9.2% of all cancer-related deaths [3]. It ranks third among the most common cancers and stands as the second leading cause of cancer-related deaths [1, 2]. The geographical distribution of colorectal cancer exhibits substantial disparities, with higher rates reported in developed countries compared to developing nations [4]. These variations can be attributed to differences in risk factors, healthcare infrastructure, and socioeconomic factors [5, 6].

Colorectal cancer arises from the malignant transformation of the colon or rectal epithelium and is influenced by a complex interplay of genetic and environmental factors [7]. Lifestyle choices, such as diet, physical activity, and tobacco use, have been identified as modifiable risk factors for colorectal cancer [8, 9]. Additionally, age, family history of the disease, and certain hereditary syndromes contribute to an individual’s susceptibility to colorectal cancer [10]. This highlights the need for public health strategies promoting increased physical activity, healthy diets, smoking cessation, and other beneficial lifestyle changes as part of comprehensive colorectal cancer control.

Research on the global burden of colorectal cancer has identified the Human Development Index (HDI) as a significant factor influencing its incidence and mortality rates. The HDI is a composite metric of social and economic development that includes factors such as life expectancy, education, and income [11]. Research has shown a positive correlation between higher HDI levels and increased colorectal cancer incidence, attributed to increased availability and utilization of screening and diagnostic procedures in more developed nations [4, 12, 13]. In 2018, the incidence of colorectal cancer was highest in areas with very high HDI, with a rate of 61.4 cases per 100,000 population. High HDI areas had an incidence rate of 24.1, followed by medium HDI areas at 6.35, and low HDI areas at 3.6. The mortality rate due to colorectal cancer also varied based on the level of development, with very high HDI areas having a mortality rate of 27.1, followed by high HDI areas at 13, medium HDI areas at 3.9, and low HDI areas at 2.75 [3].

Though colorectal cancer incidence has declined in some high-income countries, it is rising in several low- and middle-income regions, underscoring the pressing need for comprehensive prevention and control strategies [14]. Early detection through screening programs, coupled with effective treatment modalities, can significantly improve patient outcomes and reduce mortality rates [1].

This paper aims to explore global colorectal cancer incidence, mortality, and geographical disparities, correlating them with the HDI. By analyzing available data, we aim to pinpoint key drivers of the colorectal cancer burden and propose evidence-based strategies for prevention, early detection, and treatment. Understanding the worldwide landscape of colorectal cancer is vital for guiding public health policies and interventions to mitigate its impact on individuals and communities.

Materials and methods

This research utilizes data from the International Agency for Research on Cancer’s (IARC) GLOBOCAN 2020 project, an esteemed source of up-to-date international cancer statistics. The database includes information on the incidence and mortality rates of different types of cancer across 184 countries. It covers a wide range of cancer types, age groups, genders, and global regions. Developed by the World Health Organization (WHO), GLOBOCAN enables researchers to thoroughly investigate and compare cancer rates based on multiple criteria. As a highly reliable data source, GLOBOCAN provides the foundation for analyzing colorectal cancer incidence and mortality in this study [14-16].

This study primarily analyzes the Age-Standardized Incidence Rate (ASIR) and Age-Standardized Mortality Rate (ASMR) of colorectal cancer. The analysis categorizes and presents the rates based on multiple criteria: Continents: Latin America and Caribbean, Africa, Northern America, Oceania, Europe, Asia. WHO regions: Africa (AFRO), East Mediterranean (EMRO), Americas (PAHO), South-East Asia (SEARO), Europe (EURO), Western Pacific (WPRO). Global regions: Southeastern Asia, Western Asia, South-Central Asia, Eastern Asia, North America, South America, Central America, Middle Africa, Western Africa, Southern Africa, Northern Africa, Eastern Africa, Central/Eastern Europe, Southern Europe, Northern Europe, Western Europe, Caribbean, Australia/New Zealand, Melanesia, Micronesia, Polynesia. Income level: Low-income, lower-middle income, upper-middle income, High-income. The standardized rates allow comparative analysis of colorectal cancer incidence and mortality across these different geographic regions and economic groups.

HUMAN DEVELOPMENT INDEX (HDI)

The HDI is a comprehensive measure that assesses a country’s achievements in key dimensions of human development. These dimensions include education, life expectancy, and per capita income. By taking the geometric mean of normalized indices for each dimension, the HDI produces values that range from 0 to 1. In essence, the HDI provides a multi-faceted evaluation of human development by combining health, education, and economic prosperity metrics [17].

STATISTICAL ANALYSIS

This study presents 2020 incidence and mortality rates for colorectal cancer, including both raw and Age-Standardized rates per 100,000 individuals. Geographical distribution maps were created based on the Age-Standardized rates. The methodology has been extensively detailed in previous reports [12, 13, 18-20]. Specifically, the Pearson correlation method was used to analyze the relationship between ASIR and ASMR of colorectal cancer and the Human Development Index (HDI) and its components. A p-value < 0.05 was considered statistically significant, with all reported P-values being two-sided. SPSS software (Version 26.0, SPSS Inc.) performed the statistical analyses.

Results

GEOGRAPHICAL DISTRIBUTION IN THE WORLD

In 2020, there were 1,931,590 new global colorectal cancer cases - 1,065,960 (55.18%) in men and 865,630 (44.82%) in women. The ASIR was 19.5 overall, 23.4 for men and 16.2 for women. The sex ratio of new cases was 1.23 (Fig. 1).

Fig. 1.

Fig. 1.

Distribution of new Colorectal Cancer cases worldwide in 2020.

Additionally, 935,173 deaths were attributed to colorectal cancer that year. Of these, 515,637 (55.13%) occurred in men and 419,536 (44.87%) in women. The ASMR was 9 overall, 11 for men and 7.2 for women. The sex ratio for mortality was also 1.23 (Fig. 2).

Fig. 2.

Fig. 2.

Distribution of Colorectal Cancer mortality worldwide in 2020.

GEOGRAPHICAL DISTRIBUTION BASED ON THE CONTINENTS

For ASIR, Europe had the highest rate at 30.4 (37.9 for men, 24.6 for women), followed by Oceania at 29.8 (33.8 for men, 26.1 for women), then Northern America at 26.2 (29.4 for men, 23.4 for women). Rates were lower in Asia at 17.6 (21.1 for men, 14.3 for women), Latin America/Caribbean at 16.6 (18.7 for men, 15.1 for women), and Africa at 8.4 (9.4 for men, 7.6 for women). Asia had the highest proportion of cases (52.25%), followed by Europe (26.91%), North America (9.34%), Latin America/Caribbean (6.98%), Africa (3.42%), and Oceania (1.06%) (Tab. I, Fig. 1).

Tab. I.

The age-standardized incidence rate of Colorectal Cancer in different regions of the world in 2020.

Population Numbers All Men Women
Numbers Crude Rate ASR (W) Numbers Crude Rate ASR (W) Numbers Crude Rate ASR (W)
World 1 931 590 24.8 19.5 1 065 960 27.1 23.4 865 630 22.4 16.2
WHO regions WHO Africa (AFRO) 50 696 4.5 8.4 26 243 4.7 9.5 24 453 4.4 7.5
WHO Americas (PAHO) 315 518 30.8 20.7 162 356 32.2 23.3 153 162 29.5 18.5
WHO East Mediterranean (EMRO) 50 403 6.9 9.0 28 269 7.5 10.2 22 134 6.3 7.9
WHO Europe (EURO) 554 569 59.4 28.8 300 443 66.4 36.0 254 126 52.9 23.3
WHO South-East Asia (SEARO) 141 928 7.0 7.0 83 942 8.1 8.5 57 986 5.9 5.5
WHO Western Pacific (WPRO) 818 060 41.6 25.3 464 483 46.5 30.6 353 577 36.6 20.5
Continents Africa 66 198 4.9 8.4 34 060 5.1 9.4 32 138 4.8 7.6
Asia 1 009 400 21.8 17.6 576 754 24.3 21.1 432 646 19.1 14.3
Europe 519 820 69.4 30.4 281 714 77.9 37.9 238 106 61.5 24.6
Latin America and the Caribbean 134 943 20.6 16.6 67 218 20.9 18.5 67 725 20.4 15.1
Northern America 180 575 49.0 26.2 95 138 52.1 29.4 85 437 45.9 23.4
Oceania 20 654 48.4 29.8 11 076 51.8 33.8 9 578 44.9 26.1
Income levels High income 819 143 66.6 30.2 450 564 73.5 36.2 368 579 59.7 25.0
Upper middle income 887 025 30.4 21.4 490 846 33.4 25.5 396 179 27.3 17.8
Low middle income 194 954 6.4 7.4 109 105 7.1 8.6 85 849 5.8 6.3
Low income 29 542 4.9 8.8 14 959 5.0 9.7 14 583 4.8 8.0
Global regions Australia and New Zealand 19 644 64.8 33.2 10 491 69.6 37.4 9 153 60.0 29.2
Caribbean 11 454 26.3 18.2 5 327 24.8 18.5 6 127 27.8 17.8
Central America 19 535 10.9 10.4 10 181 11.6 12.0 9 354 10.2 9.1
Central and Eastern Europe 172 950 59.0 29.3 89 189 64.7 38.4 83 761 54.0 23.4
Eastern Africa 18 306 4.1 7.9 8 888 4.0 8.6 9 418 4.2 7.5
Eastern Asia 757 849 45.2 25.9 431 501 50.4 31.2 326 348 39.7 21.0
Melanesia 804 7.2 11.4 466 8.2 14.2 338 6.2 9.0
Micronesia 93 16.9 16.6 51 18.4 19.5 42 15.5 14.2
Middle Africa 5 767 3.2 6.8 3 045 3.4 7.7 2 722 3.0 6.1
Northern Africa 20 858 8.5 9.7 10 662 8.6 10.4 10 196 8.3 9.1
Northern America 180 575 49.0 26.2 95 138 52.1 29.4 85 437 45.9 23.4
Northern Europe 81 638 76.8 33.6 44 464 84.7 39.2 37 174 69.1 28.8
Polynesia 113 16.5 15.5 68 19.6 19.2 45 13.4 11.9
South America 103 954 24.1 18.5 51 710 24.4 20.6 52 244 23.9 16.8
South-Central Asia 102 987 5.1 5.5 61 252 5.9 6.6 41 735 4.3 4.4
South-Eastern Asia 106 995 16.0 14.8 60 505 18.1 18.4 46 490 13.9 11.9
Southern Africa 7 684 11.4 13.7 3 919 11.8 16.7 3 765 11.0 11.7
Southern Europe 123 588 80.6 31.9 71 009 94.7 40.6 52 579 67.0 24.5
Western Africa 13 583 3.4 6.7 7 546 3.7 7.9 6 037 3.0 5.7
Western Asia 41 569 14.9 16.8 23 496 16.1 19.9 18 073 13.6 14.0
Western Europe 141 644 72.2 28.7 77 052 80.0 34.3 64 592 64.7 23.9

For ASMR, Europe again had the highest rate at 12.3 (16.1 for men, 9.5 for women), followed by Oceania at 9.3 (11.2 for men, 7.5 for women). Rates were lower in Asia at 8.6 (10.6 for men, 6.8 for women), Latin America/Caribbean at 8.2 (9.7 for men, 6.8 for women), Northern America at 8.2 (9.4 for men, 7.3 for women), and Africa at 5.6 (6.3 for men, 5.0 for women). Mirroring incidence, Asia had the most deaths (54.15%) followed by Europe (26.17%), Latin America/Caribbean (7.42%), Northern America (6.84%), Africa (4.58%), and Oceania (0.81%) (Tab. II, Fig. 2).

Tab. II.

The age-standardized mortality rate of Colorectal Cancer in different regions of the world in 2020.

Population Numbers All Men Women
Numbers Crude Rate ASR (W) Numbers Crude Rate ASR (W) Numbers Crude Rate ASR (W)
World 935 173 12.0 9.0 515 637 13.1 11.0 419 536 10.9 7.2
WHO regions WHO Africa (AFRO) 34 132 3.0 5.8 17 634 3.2 6.7 16 498 2.9 5.2
WHO Americas (PAHO) 133 422 13.0 8.1 69 081 13.7 9.4 64 341 12.4 7.0
WHO East Mediterranean (EMRO) 27 975 3.8 5.1 15 702 4.2 5.8 12 273 3.5 4.5
WHO Europe (EURO) 263 314 28.2 12.0 141 801 31.3 15.6 121 513 25.3 9.3
WHO South-East Asia (SEARO) 80 084 4.0 4.0 47 876 4.6 4.9 32 208 3.3 3.1
WHO Western Pacific (WPRO) 396 048 20.2 11.5 223 433 22.4 14.3 172 615 17.9 9.0
Continents Africa 42 875 3.2 5.6 22 046 3.3 6.3 20 829 3.1 5.0
Asia 506 449 10.9 8.6 288 525 12.2 10.6 217 924 9.6 6.8
Europe 244 824 32.7 12.3 131 885 36.5 16.1 112 939 29.2 9.5
Latin America and the Caribbean 69 435 10.6 8.2 34 976 10.9 9.4 34 459 10.4 7.3
Northern America 63 987 17.3 8.2 34 105 18.7 9.7 29 882 16.0 6.8
Oceania 7 603 17.8 9.3 4 100 19.2 11.2 3 503 16.4 7.5
Income levels High income 340 272 27.6 10.5 185 111 30.2 13.2 155 161 25.1 8.2
Upper middle income 461 511 15.8 10.8 256 244 17.5 13.3 205 267 14.1 8.6
Low middle income 112 556 3.7 4.3 63 703 4.1 5.1 48 853 3.3 3.6
Low income 20 392 3.4 6.2 10 343 3.4 6.9 10 049 3.3 5.5
Global regions Australia and New Zealand 7 038 23.2 9.5 3 755 24.9 11.4 3 283 21.5 7.7
Caribbean 6 983 16.0 10.4 3 307 15.4 11.0 3 676 16.7 9.8
Central America 10 439 5.8 5.5 5 494 6.2 6.4 4 945 5.4 4.7
Central and Eastern Europe 93 384 31.9 14.5 48 378 35.1 20.2 45 006 29.0 11.0
Eastern Africa 13 236 3.0 5.9 6 365 2.9 6.4 6 871 3.1 5.5
Eastern Asia 368 072 21.9 11.8 208 090 24.3 14.7 159 982 19.4 9.2
Melanesia 452 4.1 6.7 279 4.9 8.8 173 3.2 4.8
Micronesia 53 9.7 9.5 29 10.5 11.7 24 8.8 7.8
Middle Africa 4 228 2.4 5.2 2 222 2.5 5.9 2 006 2.2 4.6
Northern Africa 11 530 4.7 5.4 5 900 4.8 5.9 5 630 4.6 5.0
Northern America 63 987 17.3 8.2 34 105 18.7 9.7 29 882 16.0 6.8
Northern Europe 33 768 31.8 11.4 17 811 33.9 13.5 15 957 29.7 9.6
Polynesia 60 8.8 8.4 37 10.7 10.9 23 6.8 6.3
South America 52 013 12.1 8.9 26 175 12.3 10.2 25 838 11.8 7.8
South-Central Asia 59 206 2.9 3.2 35 848 3.5 3.9 23 358 2.4 2.5
South-Eastern Asia 57 064 8.5 7.9 32 205 9.6 10.1 24 859 7.4 6.1
Southern Africa 3 943 5.8 7.2 2 052 6.2 9.1 1 891 5.5 5.9
Southern Europe 55 406 36.1 11.5 31 583 42.1 15.1 23 823 30.4 8.5
Western Africa 9 938 2.5 5.1 5 507 2.7 6.1 4 431 2.2 4.3
Western Asia 22 107 7.9 8.9 12 382 8.5 10.7 9 725 7.3 7.3
Western Europe 62 266 31.7 10.2 34 113 35.4 13.1 28 153 28.2 7.8

GEOGRAPHICAL DISTRIBUTION ACCORDING TO THE WHO CLASSIFICATION

The ASIR for colorectal cancer varied by WHO region. The highest rate was in EURO at 28.8 (36 for men, 23.3 for women), followed by WPRO at 25.3 (30.6 for men, 20.5 for women), PAHO at 20.7 (23.3 for men, 18.5 for women), EMRO at 9 (10.2 for men, 7.9 for women), AFRO at 8.4 (9.5 for men, 7.5 for women), and SEARO at 7 (8.5 for men, 5.5 for women). WPRO had the highest proportion of cases (42.36%), followed by EURO (28.72%), PAHO (16.34%), SEARO (7.35%), AFRO (2.63%), and EMRO (2.61%) (Tab. I).

For ASMR, EURO again had the highest rate at 12 (15.6 for men, 9.3 for women), followed by WPRO at 11.5 (14.3 for men, 9 for women), PAHO at 8.1 (9.4 for men, 7 for women), AFRO at 5.8 (6.7 for men, 5.2 for women), EMRO at 5.1 (5.8 for men, 4.5 for women), and SEARO at 4 (4.9 for men, 3.1 for women). WPRO had the highest proportion of cases (42.36%), followed by EURO (28.16%), PAHO (14.27%), SEARO (8.57%), AFRO (3.65%), and EMRO (2.99%) (Tab. II).

GEOGRAPHICAL DISTRIBUTION IN THE COUNTRIES

The study revealed that China, the United States of America, and Japan had the highest number of new colorectal cancer cases, with 555,477, 155,008, and 148,505 cases, respectively. On the other hand, Sao Tome and Principe, Vanuatu, and Comoros had the lowest number of cases, with 8, 10, and 20 cases, respectively. Furthermore, Hungary (45.3 per 100,000), Slovakia (43.9), and Norway (41.9) had the highest ASIR of colorectal cancer, while Guinea (3.3), The Republic of the Gambia (3.7), and Bhutan (3.8) had the lowest (Tab. S1).

Tab. S1.

Standardized rate of incidence and mortality of Colorectal Cancer in the countries of the world.

Population ASIR ASIR in males ASIR in females ASMR ASMR in males ASMR in females
Afghanistan 5.7 6.3 5.1 3.8 4.2 3.5
Albania 7.7 8.8 6.8 3.8 4.4 3.4
Algeria 15.3 16.5 14.2 8.3 9.0 7.7
Angola 7.2 9.6 5.2 5.2 7.0 3.8
Argentina 25.1 31.0 20.6 12.6 16.3 9.9
Armenia 20.1 22.2 18.5 11.3 12.2 10.6
Australia 33.1 37.3 29.2 8.9 10.8 7.2
Austria 21.0 26.5 16.4 8.7 11.6 6.3
Azerbaijan 14.2 17.8 11.5 8.6 11.3 6.6
Bahamas 16.0 20.5 12.4 10.7 13.5 8.6
Bahrain 13.9 13.7 14.6 7.1 6.8 7.5
Bangladesh 3.8 4.2 3.3 2.3 2.6 2.0
Barbados 25.1 30.5 20.4 16.1 20.9 11.9
Belarus 30.2 39.4 24.8 14.1 19.7 10.9
Belgium 35.3 43.6 28.0 10.0 12.6 7.8
Belize 6.2 5.9 6.6 6.0 5.3 6.6
Benin 7.7 11.3 5.0 5.7 8.5 3.7
Bhutan 3.8 5.4 1.9 2.5 3.7 1.1
Bolivia, Plurinational State of 5.7 6.3 5.1 3.4 3.9 2.9
Bosnia and Herzegovina 27.0 34.6 20.8 14.5 19.6 10.5
Botswana 4.5 4.3 4.5 2.6 2.5 2.6
Brazil 19.4 21.7 17.6 9.0 10.3 7.9
Brunei Darussalam 34.9 42.2 27.7 14.6 18.1 11.2
Bulgaria 27.4 36.6 20.3 14.7 20.7 10.3
Burkina Faso 3.8 3.6 3.8 3.1 3.0 3.1
Burundi 6.9 7.4 6.6 5.6 6.1 5.2
Cabo Verde 8.8 12.6 7.7 3.5 5.0 3.0
Cambodia 12.3 13.7 11.2 7.4 8.4 6.7
Cameroon 7.1 8.0 6.4 5.2 5.9 4.6
Canada 31.2 34.7 27.9 9.9 12.0 8.0
Central African Republic 6.5 7.2 6.0 5.4 6.1 4.9
Chad 6.9 7.9 6.0 5.7 6.5 5.0
Chile 19.9 22.6 17.7 9.4 11.0 8.1
China 23.9 28.6 19.5 12.0 14.8 9.4
Colombia 16.9 17.3 16.7 8.2 8.5 7.9
Comoros 4.5 3.7 5.2 3.0 2.3 3.7
Congo, Democratic Republic of 6.7 7.1 6.3 5.1 5.5 4.8
Congo, Republic of 6.3 6.9 5.8 4.4 5.0 4.0
Costa Rica 17.2 17.6 16.8 9.5 10.2 8.8
Côte d’Ivoire
Croatia 36.3 50.8 24.9 19.6 28.2 13.5
Cuba 20.1 17.9 22.0 11.3 10.7 11.8
Cyprus 24.3 35.6 14.3 10.7 14.0 7.9
Czechia 33.7 44.4 25.2 12.3 17.0 8.6
Denmark 40.9 47.1 35.6 11.8 13.7 10.2
Djibouti 6.9 7.8 5.9 5.3 6.1 4.6
Dominican Republic 12.9 13.2 12.5 7.5 8.0 7.0
Ecuador 12.9 12.5 13.2 6.4 6.4 6.3
Egypt 6.1 5.8 6.2 3.4 3.3 3.4
El Salvador 8.5 9.5 7.7 4.5 5.1 4.1
Equatorial Guinea 6.9 8.3 5.5 4.8 5.7 3.9
Eritrea 7.5 8.0 7.1 5.8 6.3 5.5
Estonia 28.3 35.6 23.9 13.8 18.6 11.1
Eswatini 4.1 4.9 3.2 3.0 3.8 2.2
Ethiopia 8.9 9.9 8.1 6.8 7.5 6.2
Fiji 10.9 11.7 10.3 6.8 8.1 5.9
Finland 25.7 29.4 22.8 8.8 10.9 7.2
France 30.1 36.3 24.9 10.4 13.3 8.1
Gabon 7.3 8.8 5.9 4.2 5.0 3.3
Gaza Strip and West Bank
Georgia 15.6 18.8 13.5 8.3 10.6 6.8
Germany 25.8 30.4 21.8 9.9 12.9 7.3
Ghana 3.9 4.4 3.6 2.8 3.2 2.5
Greece 26.9 34.4 20.5 10.7 14.1 7.8
Guatemala 5.7 6.0 5.4 3.6 3.8 3.4
Guinea 3.3 3.9 2.9 2.6 3.1 2.3
Guinea-Bissau 4.7 5.9 3.8 3.8 4.9 3.1
Guyana 8.5 9.4 7.5 5.0 5.8 4.3
Haiti 12.5 11.6 13.2 8.7 8.2 9.2
Honduras 8.0 8.5 7.6 4.2 4.6 3.9
Hungary 45.3 62.0 33.1 20.2 29.0 14.0
Iceland 28.5 32.8 24.3 9.5 10.9 8.1
India 4.8 6.0 3.7 2.8 3.6 2.1
Indonesia 12.4 16.5 8.6 6.7 9.2 4.6
Iran, Islamic Republic of 13.9 15.9 11.9 7.3 8.3 6.3
Iraq 8.7 10.8 6.9 5.4 6.8 4.4
Ireland 34.9 42.6 27.9 12.4 15.7 9.4
Israel 21.9 24.5 19.8 9.0 10.3 7.9
Italy 29.3 34.2 25.2 10.1 12.7 8.1
Jamaica 21.1 26.4 16.3 13.4 17.2 9.8
Japan 38.5 47.3 30.5 11.6 14.7 8.9
Jordan 17.7 17.2 18.4 9.6 9.7 9.6
Kazakhstan 15.6 18.0 14.3 9.2 11.7 7.6
Kenya 10.5 11.9 9.7 7.5 8.7 6.9
Korea, Democratic Republic of 18.8 22.8 15.9 10.9 13.5 8.7
Korea, Republic of 27.2 34.9 20.6 7.8 10.8 5.5
Kuwait 12.5 13.1 11.9 6.6 7.0 6.1
Kyrgyzstan 7.8 8.8 7.0 5.4 5.9 4.9
Lao People’s Democratic Republic 15.0 16.1 14.2 8.9 10.1 7.9
Latvia 36.8 48.8 30.1 12.3 15.9 10.4
Lebanon 12.2 15.2 9.5 6.7 8.8 5.0
Lesotho 5.3 7.8 4.0 3.8 6.0 2.8
Liberia 4.9 5.5 4.4 3.9 4.4 3.5
Libya 15.7 16.7 15.1 10.2 11.0 9.8
Lithuania 27.6 36.4 22.3 11.7 16.1 9.4
Luxembourg 26.3 29.7 23.7 8.7 11.2 6.4
Madagascar 6.2 5.6 6.8 4.7 4.3 5.1
Malawi 4.9 6.3 4.1 3.9 5.0 3.3
Malaysia 19.6 21.2 18.0 10.2 11.0 9.4
Maldives 13.0 16.4 9.3 7.4 10.5 4.1
Mali 9.2 8.8 9.6 7.5 7.2 7.7
Malta 25.7 31.1 21.2 10.1 11.9 8.6
Mauritania 7.2 8.6 6.1 5.4 6.5 4.6
Mauritius 17.8 21.9 14.7 7.9 9.5 6.6
Mexico 10.6 12.4 9.1 5.4 6.4 4.6
Mongolia 6.3 6.6 6.1 4.0 4.0 4.0
Montenegro 27.4 35.2 21.1 13.7 21.5 7.8
Morocco 11.3 12.9 9.9 6.2 7.2 5.4
Mozambique 4.1 3.6 4.4 3.2 2.8 3.5
Myanmar 9.7 11.8 8.2 5.8 7.3 4.8
Namibia 8.2 10.8 6.4 5.8 7.6 4.4
Nepal 4.3 5.5 3.4 2.5 3.2 1.9
New Zealand 33.8 38.3 29.7 12.3 14.5 10.3
Nicaragua 10.5 10.4 10.5 6.0 5.8 6.0
Niger 7.0 8.0 5.9 5.8 6.6 4.9
Nigeria 7.3 8.6 6.0 5.5 6.5 4.5
North Macedonia 26.1 26.6 26.1 13.0 13.9 12.3
Norway 41.9 45.4 38.7 13.5 15.1 12.1
Oman 9.9 11.2 7.7 5.7 6.2 4.5
Pakistan 5.3 6.2 4.4 3.0 3.5 2.5
Panama 13.9 16.3 11.7 7.3 9.0 5.8
Papua New Guinea 11.3 14.5 8.4 6.9 9.2 4.8
Paraguay 18.6 20.5 16.7 9.3 10.5 8.1
Peru 11.4 11.6 11.1 5.6 5.9 5.3
Philippines 18.8 23.7 15.1 10.1 13.4 7.8
Poland 30.5 41.7 21.9 16.1 22.8 11.3
Portugal 39.4 55.2 26.6 13.0 18.6 8.8
Puerto Rico 26.3 32.1 22.0 12.4 15.7 9.9
Qatar 15.7 13.6 20.6 9.0 8.0 10.9
Republic of Moldova 30.0 44.3 19.7 17.6 26.7 11.3
Romania 30.9 41.9 22.4 14.8 21.1 10.2
Russian Federation 27.8 34.4 23.9 13.9 18.6 11.3
Rwanda 5.3 6.6 4.2 4.0 4.9 3.1
Saudi Arabia 13.9 16.1 10.9 7.3 8.7 5.6
Senegal 6.7 7.4 6.2 5.1 5.7 4.7
Serbia 33.6 46.4 22.8 16.7 23.7 11.1
Sierra Leone 5.0 6.0 4.1 4.1 5.0 3.3
Singapore 33.0 38.6 27.4 16.2 19.8 12.8
Slovakia 43.9 60.7 31.1 21.0 29.6 14.8
Slovenia 39.6 55.8 25.4 11.7 16.1 8.4
Solomon Islands 6.7 6.5 7.0 4.2 4.9 3.5
Somalia 9.3 10.1 8.6 7.7 8.4 7.1
South Africa 14.6 17.6 12.5 7.5 9.5 6.2
South Sudan 5.7 6.3 5.1 4.5 5.1 4.0
Spain 35.8 47.7 25.4 11.5 15.5 8.2
Sri Lanka 7.8 7.7 7.9 3.7 3.8 3.7
Sudan 6.3 6.6 6.0 3.9 4.2 3.6
Suriname 18.1 21.3 15.9 11.3 14.3 8.8
Sweden 27.8 30.5 25.2 10.8 12.1 9.7
Switzerland 22.3 25.7 19.4 7.5 9.1 6.2
Syrian Arab Republic 12.9 14.4 11.7 8.2 9.4 7.2
Tajikistan 4.7 6.7 2.9 3.2 4.5 2.0
Tanzania, United Republic of 8.5 7.7 9.3 6.3 5.8 6.8
Thailand 16.9 19.0 15.2 8.4 9.7 7.5
The Netherlands 41.0 48.4 34.3 13.5 16.2 11.1
The Republic of the Gambia
Timor-Leste 8.9 10.1 7.9 5.0 6.2 4.0
Togo 8.2 12.1 5.0 6.3 9.3 3.8
Trinidad and Tobago 18.5 23.0 14.7 11.0 13.7 8.8
Tunisia 12.7 14.0 11.7 6.4 7.3 5.6
Turkey 20.6 26.2 16.2 10.1 13.0 7.8
Turkmenistan 6.2 7.0 5.7 3.8 4.3 3.3
Uganda 6.7 7.8 6.0 5.0 5.9 4.4
Ukraine 25.5 33.6 20.5 12.9 18.1 9.9
United Arab Emirates 13.1 11.5 17.3 6.9 6.2 8.7
United Kingdom 34.1 40.0 29.0 11.4 13.5 9.6
United States of America 25.6 28.7 22.9 8.0 9.4 6.7
Uruguay 32.0 40.6 25.6 14.3 19.3 10.9
Uzbekistan 8.9 9.5 8.5 5.2 5.7 4.8
Vanuatu 5.2 4.2 6.3 4.8 4.2 5.4
Venezuela, Bolivarian Republic of 14.2 15.0 13.4 7.8 8.6 7.1
Viet Nam 14.1 17.6 11.6 7.0 9.1 5.5
Yemen 10.7 12.0 9.5 7.7 8.6 6.9
Zambia 5.6 6.3 5.3 4.0 4.8 3.7
Zimbabwe 8.9 10.4 8.0 6.4 7.8 5.6

When it comes to mortality, China recorded the highest number of colorectal cancer cases (286,162 cases), followed by Japan (59,912 cases), and the United States of America (54,443 cases). Conversely, Sao Tome and Principe (5 cases), Vanuatu (9 cases), and Comoros (13 cases) had the lowest number of cases. Slovakia (21), Hungary (20.2), and Croatia (19.6) had the highest ASMR of colorectal cancer, while Bangladesh (2.3), Bhutan (2.5), and Nepal (2.5) had the lowest (Tab. S2).

Tab. S2.

Human development index and its components for different countries of the world.

HDI rank Population HDI Life expectancy at birth Mean years of schooling Gross national Income (GNI) per capita
1 Norway 0.96 82.40 12.90 66494
2 Switzerland 0.96 83.80 13.40 69394
3 Ireland 0.96 82.30 12.70 68371
4 Germany 0.95 81.30 14.20 55314
4 Iceland 0.95 83.00 12.80 54682
7 Australia 0.94 83.40 12.70 48085
7 Sweden 0.95 82.80 12.50 54508
9 The Netherlands 0.94 82.30 12.40 57707
10 Denmark 0.94 80.90 12.60 58662
11 Finland 0.94 81.90 12.80 48511
12 Singapore 0.94 83.60 11.60 88155
13 Belgium 0.93 81.60 12.10 52085
14 Canada 0.93 82.40 13.40 48527
14 New Zealand 0.93 82.30 12.80 40799
14 United Kingdom 0.93 81.30 13.20 46071
17 United States of America 0.93 78.90 13.40 63826
18 Austria 0.92 81.50 12.50 56197
20 Japan 0.92 84.60 12.90 42932
21 Israel 0.92 83.00 13.00 40187
22 Korea, Republic of 0.92 83.00 12.20 43044
23 Luxembourg 0.92 82.30 12.30 72712
24 Slovenia 0.92 81.30 12.70 38080
25 Spain 0.90 83.60 10.30 40975
26 Czechia 0.90 79.40 12.70 38109
26 France 0.90 82.70 11.50 47173
28 Malta 0.90 82.50 11.30 39555
29 Italy 0.89 83.50 10.40 42776
30 Estonia 0.89 78.80 13.10 36019
30 United Arab Emirates 0.89 78.00 12.10 67462
32 Cyprus 0.89 81.00 12.20 38207
33 Greece 0.89 82.20 10.60 30155
34 Poland 0.88 78.70 12.50 31623
35 Lithuania 0.88 75.90 13.10 35799
37 Latvia 0.87 75.30 13.00 30282
38 Portugal 0.86 82.10 9.30 33967
39 Slovakia 0.86 77.50 12.70 32113
40 Saudi Arabia 0.85 75.10 10.20 47495
41 Bahrain 0.85 77.30 9.50 42522
42 Hungary 0.85 76.90 12.00 31329
43 Chile 0.85 80.20 10.60 23261
44 Croatia 0.85 78.50 11.40 28070
45 Qatar 0.85 80.20 9.70 92418
46 Argentina 0.85 76.70 10.90 21190
47 Brunei Darussalam 0.84 75.90 9.10 63965
48 Montenegro 0.83 76.90 11.60 21399
49 Belarus 0.82 74.80 12.30 18546
49 Romania 0.83 76.10 11.10 29497
49 Russian Federation 0.82 72.60 12.20 26157
53 Kazakhstan 0.83 73.60 11.90 22857
54 Turkey 0.82 77.70 8.10 27701
55 Bulgaria 0.82 75.10 11.40 23325
56 Oman 0.81 77.90 9.70 25944
56 Uruguay 0.82 77.90 8.90 20064
58 Bahamas 0.81 73.90 11.40 33747
58 Panama 0.82 78.50 10.20 29558
60 Barbados 0.81 79.20 10.60 14936
61 Costa Rica 0.81 80.30 8.70 18486
62 Kuwait 0.81 75.50 7.30 58590
63 Georgia 0.81 73.80 13.10 14429
63 Malaysia 0.81 76.20 10.40 27534
65 Serbia 0.81 76.00 11.20 17192
66 Mauritius 0.80 75.00 9.50 25266
67 Trinidad and Tobago 0.80 73.50 11.00 26231
68 Albania 0.80 78.60 10.10 13998
70 Iran, Islamic Republic of 0.78 76.70 10.30 12447
71 Cuba 0.78 78.80 11.80 8621
72 Armenia 0.78 75.10 11.30 13894
73 Sri Lanka 0.78 77.00 10.60 12707
76 Bosnia and Herzegovina 0.78 77.40 9.80 14872
76 Mexico 0.78 75.10 8.80 19160
78 Peru 0.78 76.70 9.70 12252
78 Ukraine 0.78 72.10 11.40 13216
80 Thailand 0.78 77.20 7.90 17781
82 North Macedonia 0.77 75.80 9.80 15865
83 Colombia 0.77 77.30 8.50 14257
84 Brazil 0.77 75.90 8.00 14263
84 Ecuador 0.76 77.00 8.90 11044
87 China 0.76 76.90 8.10 16057
88 Azerbaijan 0.76 73.00 10.60 13784
89 Dominican Republic 0.76 74.10 8.10 17591
90 Lebanon 0.74 78.90 8.70 14655
91 Algeria 0.75 76.90 8.00 11174
91 Republic of Moldova 0.75 71.90 11.70 13664
93 Fiji 0.74 67.40 10.90 13009
94 Tunisia 0.74 76.70 7.20 10414
97 Mongolia 0.74 69.90 10.30 10839
98 Jamaica 0.73 74.50 9.70 9319
98 Maldives 0.74 78.90 7.00 17417
98 Suriname 0.74 71.70 9.30 14324
101 Venezuela, Bolivarian Republic of 0.71 72.10 10.30 7045
102 Botswana 0.74 69.60 9.60 16437
103 Jordan 0.73 74.50 10.50 9858
104 Paraguay 0.73 74.30 8.50 12224
106 Libya 0.72 72.90 7.60 15688
107 Uzbekistan 0.72 71.70 11.80 7142
108 Belize 0.72 74.60 9.90 6382
108 Bolivia, Plurinational State of 0.72 71.50 9.00 8554
110 Indonesia 0.72 71.70 8.20 11459
111 Philippines 0.72 71.20 9.40 9778
112 Turkmenistan 0.72 68.20 10.30 14909
114 Gaza Strip and West Bank 0.71 74.10 9.20 6417
115 South Africa 0.71 64.10 10.20 12129
117 Egypt 0.71 72.00 7.40 11466
118 Viet Nam 0.70 75.40 8.30 7433
119 Gabon 0.70 66.50 8.70 13930
120 Kyrgyzstan 0.70 71.50 11.10 4864
121 Guyana 0.68 69.90 8.50 9455
121 Morocco 0.69 76.70 5.60 7368
123 Iraq 0.67 70.60 7.30 10801
124 El Salvador 0.67 73.30 6.90 8359
125 Cabo Verde 0.67 73.00 6.30 7019
126 Tajikistan 0.67 71.10 10.70 3954
127 Nicaragua 0.66 74.50 6.90 5284
128 Guatemala 0.66 74.30 6.60 8494
129 Namibia 0.65 63.70 7.00 9357
130 India 0.65 69.70 6.50 6681
131 Bhutan 0.65 71.80 4.10 10746
132 Honduras 0.63 75.30 6.60 5308
134 Bangladesh 0.63 72.60 6.20 4976
137 Lao People’s Democratic Republic 0.61 67.90 5.30 7413
138 Ghana 0.61 64.10 7.30 5269
139 Eswatini 0.61 60.20 6.90 7919
140 Vanuatu 0.61 70.50 7.10 3105
141 Kenya 0.60 66.70 6.60 4244
141 Timor-Leste 0.61 69.50 4.80 4440
143 Nepal 0.60 70.80 5.00 3457
144 Cambodia 0.59 69.80 5.00 4246
145 Angola 0.58 61.20 5.20 6104
145 Equatorial Guinea 0.59 58.70 5.90 13944
145 Zambia 0.58 63.90 7.20 3326
148 Myanmar 0.58 67.10 5.00 4961
149 Congo, Republic of 0.57 64.60 6.50 2879
150 Zimbabwe 0.57 61.50 8.50 2666
151 Solomon Islands 0.57 73.00 5.70 2253
152 Syrian Arab Republic 0.57 72.70 5.10 3613
153 Cameroon 0.56 59.30 6.30 3581
154 Comoros 0.55 64.30 5.10 3099
154 Pakistan 0.56 67.30 5.20 5005
156 Papua New Guinea 0.56 64.50 4.70 4301
157 Mauritania 0.55 64.90 4.70 5135
158 Benin 0.55 61.80 3.80 3254
159 Rwanda 0.54 69.00 4.40 2155
160 Uganda 0.54 63.40 6.20 2123
161 Côte d’Ivoire 0.54 57.80 5.30 5069
161 Nigeria 0.54 54.70 6.70 4910
163 Madagascar 0.53 67.00 6.10 1596
164 Tanzania, United Republic of 0.53 65.50 6.10 2600
165 Lesotho 0.53 54.30 6.50 3151
166 Djibouti 0.52 67.10 4.10 5689
167 Senegal 0.51 67.90 3.20 3309
168 Togo 0.52 61.00 4.90 1602
169 Afghanistan 0.51 64.80 3.90 2229
170 Haiti 0.51 64.00 5.60 1709
171 Sudan 0.51 65.30 3.80 3829
172 The Republic of the Gambia 0.50 62.10 3.90 2168
173 Liberia 0.48 64.10 4.80 1258
174 Congo, Democratic Republic of 0.48 60.70 6.80 1063
174 Ethiopia 0.49 66.60 2.90 2207
174 Malawi 0.48 64.30 4.70 1035
177 Guinea 0.48 61.60 2.80 2405
178 Guinea-Bissau 0.48 58.30 3.60 1996
179 Yemen 0.47 66.10 3.20 1594
180 Eritrea 0.46 66.30 3.90 2793
181 Mozambique 0.46 60.90 3.50 1250
182 Sierra Leone 0.45 54.70 3.70 1668
183 Burkina Faso 0.45 61.60 1.60 2133
184 Burundi 0.43 61.60 3.30 754
184 Mali 0.43 59.30 2.40 2269
186 South Sudan 0.43 57.90 4.80 2003
187 Chad 0.40 54.20 2.50 1555
188 Central African Republic 0.40 53.30 4.30 993
189 Niger 0.39 62.40 2.10 1201

ASIR and ASMR

Globally, there was a statistically significant positive correlation of 0.895 (p ≤ 0.001) between the ASIR and ASMR of colorectal cancer.

ASIR and HDI

Analysis revealed a significant positive correlation of 0.794 (p ≤ 0.001) between the ASIR of colorectal cancer and the HDI. Furthermore, positive correlations emerged between the ASIR and specific HDI dimensions. Namely, the ASIR correlated positively with life expectancy at birth (0.724, p ≤ 0.001), education levels (0.743, p ≤ 0.001), and income per capita (0.706, p ≤ 0.001) (Tabs. III, S1, S2).

Tab. III.

The relationship between the incidence and mortality of Colorectal Cancer with the HDI and its components.

Incidence and mortality rates HDI Life expectancy at birth Mean years of schooling Gross national Income (GNI) per capita
ASIR Boys r 0.757 0.677 0.715 0.652
p-value 0.001 0.001 0.001 0.001
Girls r 0.811 0.749 0.757 0.749
p-value 0.001 0.001 0.001 0.001
Total r 0.794 0.724 0.743 0.706
p-value 0.001 0.001 0.001 0.001
ASMR Boys r 0.604 0.519 0.606 0.459
p-value 0.001 0.001 0.001 0.001
Girls r 0.626 0.575 0.620 0.535
p-value 0.001 0.001 0.001 0.001
Total r 0.638 0.569 0.631 0.512
p-value 0.001 0.001 0.001 0.001

ASMR and HDI

The ASMR for colorectal cancer showed a significant positive correlation of 0.638 with the HDI (p = 0.001). Positive correlations were also found between the ASMR and life expectancy at birth (0.569, p ≤ 0.001), education levels (0.631, p ≤ 0.001), and income per capita (0.512, p ≤ 0.001) (Tabs. III, S1, S2).

Discussion

This comprehensive analysis reveals stark global disparities in colorectal cancer incidence and mortality, underscoring the impact of geographic differences and human development levels. With over 1.9 million new cases and 0.9 million deaths in 2020, the data highlights the considerable worldwide burden of this disease.

Geographically, incidence and mortality rates varied greatly by continent. Europe had the highest age-standardized rates while Africa had the lowest, likely reflecting disparities in risk factors, genetics, and screening access [21]. Rates also differed by WHO region, with EURO and WPRO having the highest burdens and EMRO, AFRO, and SEARO the lowest. These regional variances further emphasize how geographic factors influence colorectal cancer outcomes.

When observing the data at a country level, the highest number of new colorectal cases were recorded in China, United States, and Japan, while the lowest were in Sao Tome and Principe, Vanuatu, and Comoros. Interestingly, Hungary, Slovakia, and Norway had the highest ASIR, while Guinea, The Republic of Gambia, and Bhutan had the lowest. This discrepancy between the number of cases and ASIR can be attributed to the differences in population sizes, healthcare infrastructure, and cancer surveillance among these countries [2].

A significant positive correlation was found between global colorectal cancer ASIR and ASMR, suggesting that rising incidence rates are often paired with increasing mortality burdens [22, 23].This pattern indicates that many regions lack adequate early detection and treatment access needed to reduce colorectal cancer mortality despite rising incidence levels. Improving screening programs and treatment availability, particularly in less developed areas, is critical to curb worldwide colorectal cancer mortality rates and mitigate the impact of increasing incidence.

The study also found positive correlations between colorectal cancer’s standardized incidence and mortality rates and various HDI dimensions, including life expectancy at birth, education levels, and income. This indicates that higher human development is linked to greater colorectal cancer incidence and mortality, possibly due to several factors. These include increased life expectancy resulting in more cases among older populations, dietary and lifestyle changes accompanying development, and improved detection enabled by advanced healthcare systems [24]. This complex relationship between development and colorectal cancer epidemiology highlights the need for multifaceted control strategies encompassing prevention, screening, treatment, and research.

As noted in previous research, men consistently exhibited higher colorectal cancer incidence and mortality rates than women across all global regions analyzed [4, 12, 13, 18-20]. This sex disparity highlights the need for targeted strategies that take into account differences in risk factors, screening behaviors, treatment access, and outcomes between males and females. Gender-specific prevention and control initiatives should be considered to equitably address the worldwide colorectal cancer burden for both sexes.

These disparities could be attributed to a variety of factors, including differences in dietary habits, healthcare infrastructure, access to screening programs, and prevalence of risk factors such as smoking and obesity. For example, higher rates in developed regions might reflect better detection and reporting mechanisms, as well as lifestyle factors such as diet and physical inactivity. Conversely, lower rates in less developed regions could indicate underreporting and limited access to healthcare services [25-28].

Moreover, the observed positive correlation between the Human Development Index (HDI) and colorectal cancer incidence and mortality underscores the impact of socioeconomic factors on health outcomes. Countries with higher HDI tend to have better healthcare systems and more widespread use of screening programs, which can lead to higher detection rates. However, these same countries also exhibit lifestyle factors that increase colorectal cancer risk, such as higher consumption of red and processed meats.

It is also crucial to address potential data quality issues in the GLOBOCAN database. Variations in data collection methods, reporting accuracy, and completeness can affect the reliability of the reported incidence and mortality rates [14]. For instance, underreporting in low-income countries may lead to an underestimation of the true burden of colorectal cancer in these regions. The GLOBOCAN database relies on a combination of cancer registry data, vital statistics, and modeling techniques to estimate cancer incidence and mortality. While this approach allows for comprehensive global estimates, it also introduces potential sources of error [2, 12-14, 29].

This global analysis provides valuable insights into the varying colorectal cancer incidence and mortality rates across countries and regions. The findings can help guide targeted prevention and treatment initiatives tailored to local contexts. Further research should delve deeper into the specific factors driving regional disparities worldwide to inform more effective, context-specific strategies for combating colorectal cancer.

Overall, the results underscore the urgent need for an integrated global approach that accounts for regional differences in colorectal cancer epidemiology, socioeconomic conditions, and local healthcare capacity. Only through coordinated global action can we hope to confront the rising worldwide burden of colorectal cancer. Moving forward, global collaboration and resource mobilization focused on prevention, early detection, treatment access, research, and health system strengthening will be essential to equitably and sustainably reduce the threat posed by this disease worldwide.

LIMITATIONS OF THE STUDY

The quality of cancer data in GLOBOCAN varies, especially for medium or low HDI countries. Thus, estimates for some countries may rely on limited regional cancer recordings or be extrapolated from neighboring countries [29]. See Table S1, Tables I and II for further details on data quality issues across countries.

Conclusions

In conclusion, this study provides valuable insights into the global disparities in colorectal cancer incidence and mortality rates. It underscores the need for comprehensive strategies to reduce colorectal cancer burden, particularly in regions and countries with high incidence and mortality rates. Such strategies should include improving access to early detection and treatment, promoting lifestyle changes, and strengthening cancer surveillance systems.

Acknowledgments

This is to acknowledge that the project leading to the publication of this paper is fully funded by the research deputy of Shahrekord University of Medical Sciences in Iran with grant number: 7026 and ethical code: IR.SKUMS.REC.1402.124.

Data availability

The data used in this study can be retrieved in the tables provided in the text of the article. In addition, the data used in the present study is freely available in the globocan website (https://gco.iarc.fr/).

Conflicts of interest statement

There is no conflict of interest in this study.

Funding source

This work was supported by the research deputy of Shahrekord University of Medical Sciences in Iran with grant number: 7026 and ethical code: IR.SKUMS.REC.1402.124.

Author’s contributions

DD: Data curation, writing-original draft, preparation, reviewing, editing, methodology, and software. AMH: Data curation, writing-original draft, preparation, visualization, investigation, project administration, validation, reviewing, editing, methodology, and software. SK: Conceptualization, writing-original draft, and investigation.

History

Received on August 22, 2023. Accepted on August 19, 2024.

Figures and tables

Supplementary Materials

References

  • [1].Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, Wender RC. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 2019;69:184-210. https://doi.org/10.3322/caac.21557. 10.3322/caac.21557 [DOI] [PubMed] [Google Scholar]
  • [2].Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424. https://doi.org/10.3322/caac.21492. Erratum in: CA Cancer J Clin 2020;70:313. https://doi.org/10.3322/caac.21609. 10.3322/caac.21492 [DOI] [PubMed] [Google Scholar]
  • [3].Goodarzi E, Beiranvand R, Naemi H, Momenabadi V, Khazaei Z. Worldwide incidence and mortality of colorectal cancer and human development index (HDI): an ecological study. World Cancer Research J 2019;6:e1433. https://doi.org/10.32113/wcrj_201911_1433. 10.32113/wcrj_201911_1433 [DOI] [Google Scholar]
  • [4].Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut 2017;66:683-91. https://doi.org/10.1136/gutjnl-2015-310912. 10.1136/gutjnl-2015-310912 [DOI] [PubMed] [Google Scholar]
  • [5].Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A. Colorectal cancer statistics, 2017. CA Cancer J Clin 2017;67:177-93. https://doi.org/10.3322/caac.21395. 10.3322/caac.21395 [DOI] [PubMed] [Google Scholar]
  • [6].Araghi M, Soerjomataram I, Jenkins M, Brierley J, Morris E, Bray F, Arnold M. Global trends in colorectal cancer mortality: projections to the year 2035. Int J Cancer 2019;144:2992-3000. https://doi.org/10.1002/ijc.32055. 10.1002/ijc.32055 [DOI] [PubMed] [Google Scholar]
  • [7].Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol 2011;6:479-507. https://doi.org/10.1146/annurev-pathol-011110-130235. 10.1146/annurev-pathol-011110-130235 [DOI] [PubMed] [Google Scholar]
  • [8].Murphy N, Moreno V, Hughes DJ, Vodicka L, Vodicka P, Aglago EK, Gunter MJ, Jenab M. Lifestyle and dietary environmental factors in colorectal cancer susceptibility. Mol Aspects Med 2019;69:2-9. https://doi.org/10.1016/j.mam.2019.06.005. 10.1016/j.mam.2019.06.005 [DOI] [PubMed] [Google Scholar]
  • [9].Yang C, Wang X, Huang CH, Yuan WJ, Chen ZH. Passive Smoking and Risk of Colorectal Cancer: A Meta-analysis of Observational Studies. Asia Pac J Public Health 2016;28:394-403. https://doi.org/10.1177/1010539516650724. 10.1177/1010539516650724 [DOI] [PubMed] [Google Scholar]
  • [10].Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastroenterology 2010;138:2044-58. https://doi.org/10.1053/j.gastro.2010.01.054. 10.1053/j.gastro.2010.01.054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [11].United Nations Development Programme. Human Development Index (HDI). 2021. Available at: http://hdr.undp.org/en/indicators/137506 (Accessed on: 20/6/2023).
  • [12].Ghoncheh M, Mohammadian M, Mohammadian-Hafshejani A, Salehiniya H. The Incidence and Mortality of Colorectal Cancer and Its Relationship With the Human Development Index in Asia. Ann Glob Health 2016;82:726-37. https://doi.org/10.1016/j.aogh.2016.10.004. 10.1016/j.aogh.2016.10.004 [DOI] [PubMed] [Google Scholar]
  • [13].Rafiemanesh H, Mohammadian-Hafshejani A, Ghoncheh M, Sepehri Z, Shamlou R, Salehiniya H, Towhidi F, Makhsosi BR. Incidence and Mortality of Colorectal Cancer and Relationships with the Human Development Index across the World. Asian Pac J Cancer Prev 2016;17:2465-73. https://doi.org/10.7314/APJCP.2016.17.5.2465. 10.7314/APJCP.2016.17.5.2465 [DOI] [PubMed] [Google Scholar]
  • [14].Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71:209-49. https://doi.org/10.3322/caac.21660. 10.3322/caac.21660 [DOI] [PubMed] [Google Scholar]
  • [15].Bertuccio P, Alicandro G, Malvezzi M, Carioli G, Boffetta P, Levi F, La Vecchia C, Negri E. Cancer mortality in Europe in 2015 and an overview of trends since 1990. Ann Oncol 2019;30:1356-69. https://doi.org/10.1093/annonc/mdz179. 10.1093/annonc/mdz179 [DOI] [PubMed] [Google Scholar]
  • [16].Petrick JL, Florio AA, Znaor A, Ruggieri D, Laversanne M, Alvarez CS, Ferlay J, Valery PC, Bray F, McGlynn KA. International trends in hepatocellular carcinoma incidence, 1978-2012. Int J Cancer 2020;147:317-30. https://doi.org/10.1002/ijc.32723. 10.1002/ijc.32723 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [17].Malik K. Human development report 2013. The rise of the South: Human progress in a diverse world. The Rise of the South: Human Progress in a Diverse World (March 15, 2013) UNDP-HDRO Human Development Reports 2013. [Google Scholar]
  • [18].Rafiemanesh H, Mehtarpoor M, Mohammadian-Hafshejani A, Salehiniya H, Enayatrad M, Khazaei S. Cancer epidemiology and trends in Sistan and Baluchestan province, Iran. Med J Islam Repub Iran 2015;29:254. [PMC free article] [PubMed] [Google Scholar]
  • [19].Pakzad R, Moudi A, Pournamdar Z, Pakzad I, Mohammadian-Hashejani A, Momenimovahed Z, Salehiniya H, Towhidi F, Makhsosi BR. Spatial Analysis of Colorectal Cancer in Iran. Asian Pac J Cancer Prev 2016;17:53-8. https://doi.org/10.7314/apjcp.2016.17.s3.53. 10.7314/apjcp.2016.17.s3.53 [DOI] [PubMed] [Google Scholar]
  • [20].Salehiniya H, Ghobadi Dashdebi S, Rafiemanesh H, Mohammadian-Hafshejani A, Enayatrad M. Time Trend Analysis of Cancer Incidence in Caspian Sea, 2004-2009: A Population-based Cancer Registries Study (Northern Iran). Caspian J Intern Med 2016;7:25-30. [PMC free article] [PubMed] [Google Scholar]
  • [21].Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009;59:366-78. https://doi.org/10.3322/caac.20038. 10.3322/caac.20038 [DOI] [PubMed] [Google Scholar]
  • [22].Doubeni CA, Corley DA, Zauber AG. Colorectal Cancer Health Disparities and the Role of US Law and Health Policy. Gastroenterology 2016;150:1052-5. https://doi.org/10.1053/j.gastro.2016.03.012. 10.1053/j.gastro.2016.03.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [23].Dorsey K, Zhou Z, Masaoud R, Nimeiri HS. Health care disparities in the treatment of colorectal cancer. Curr Treat Options Oncol 2013;14:405-14. https://doi.org/10.1007/s11864-013-0241-9. 10.1007/s11864-013-0241-9 [DOI] [PubMed] [Google Scholar]
  • [24].Bray F, Soerjomataram I. The Changing Global Burden of Cancer: Transitions in Human Development and Implications for Cancer Prevention and Control. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, eds. Cancer: Disease Control Priorities. 3rd ed. (Vol. 3). Washington, DC: The International Bank for Reconstruction and Development/The World Bank; 2015. [PubMed] [Google Scholar]
  • [25].Rasool S, Kadla SA, Rasool V, Ganai BA. A comparative overview of general risk factors associated with the incidence of colorectal cancer. Tumour Biol 2013;34:2469-76. https://doi.org/10.1007/s13277-013-0876-y. 10.1007/s13277-013-0876-y [DOI] [PubMed] [Google Scholar]
  • [26].Gausman V, Dornblaser D, Anand S, Hayes RB, O’Connell K, Du M, Liang PS. Risk Factors Associated With Early-Onset Colorectal Cancer. Clin Gastroenterol Hepatol 2020;18:2752-9.e2. https://doi.org/10.1016/j.cgh.2019.10.009. 10.1016/j.cgh.2019.10.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [27].Degett TH, Dalton SO, Christensen J, Søgaard J, Iversen LH, Gögenur I. Mortality after emergency treatment of colorectal cancer and associated risk factors-a nationwide cohort study. Int J Colorectal Dis 2019;34:85-95. https://doi.org/10.1007/s00384-018-3172-x. 10.1007/s00384-018-3172-x [DOI] [PubMed] [Google Scholar]
  • [28].Iversen LH. Aspects of survival from colorectal cancer in Denmark. Dan Med J 2012;59:B4428. [PubMed] [Google Scholar]
  • [29].Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86. https://doi.org/10.1002/ijc.29210. 10.1002/ijc.29210 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Materials

Data Availability Statement

The data used in this study can be retrieved in the tables provided in the text of the article. In addition, the data used in the present study is freely available in the globocan website (https://gco.iarc.fr/).


Articles from Journal of Preventive Medicine and Hygiene are provided here courtesy of Pacini Editore

RESOURCES